Rich Miller, chief strategy officer of Qgenda, discusses how COVID-19 affected clinical capacity in the early stages of the pandemic and how it will have lasting effects on capacity management into the future.
Rich Miller, chief strategy officer of Qgenda, discusses how COVID-19 affected clinical capacity in the early stages of the pandemic and how it will have lasting effects on capacity management into the future.